05 June 2024

Clinical study shows “zAvatar-test” has high predictive power for personalising colorectal cancer treatment

Rita Fior, leader of the Cancer Development and Innate Immune Evasion Group at the Champalimaud Foundation (CF), has been studying for several years the power of zebrafish “avatars”, or zAvatars, of cancer patients to help guide therapeutic decisions. The goal: to predict individual cancer treatment outcomes, thus enabling the selection of the best available chemotherapy treatment for each patient.

04 June 2024

What am I looking at? Rainbow Riddle

The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.

Raghavendra Archak

Marco Colnaghi

Catarina Reis Dias

Ana Cristina Ojalvo

Mariana Duarte

Marcel Graetz

Francesco Trapani

Camillo Heye

Subscribe to Researchers
Loading
Please wait...